Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+2.9%
5Y CAGR+11.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+2.9%/yr
vs +23.9%/yr prior
5Y CAGR
+11.2%/yr
Recent deceleration
Acceleration
-21.0pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $39.98M | +4.4% |
| 2025 | $38.31M | -8.8% |
| 2024 | $42.00M | +14.3% |
| 2023 | $36.73M | +10.3% |
| 2022 | $33.32M | +41.6% |
| 2021 | $23.53M | +32.9% |
| 2020 | $17.71M | +13.5% |
| 2019 | $15.60M | +13.1% |
| 2018 | $13.79M | +38.1% |
| 2017 | $9.99M | - |